Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.165
+0.075 (2.43%)
May 20, 2026, 11:19 AM EDT - Market open
Lantern Pharma Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Lantern Pharma stock has a consensus rating of "Strong Buy" and an average price target of $20. The average 1-year stock price forecast is 531.91% higher than the current stock price, while the lowest is $15 (+373.93%) and the highest is $25 (+689.89%).
Price Target: $20 (+531.91%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lantern Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +689.89% | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 25, 2024 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +247.55% | Aug 10, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +247.55% | Jun 26, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +247.55% | May 25, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.60
from -1.57
EPS Next Year
-2.06
from -1.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.65 | -2.12 | |||
| Avg | -1.60 | -2.06 | |||
| Low | -1.54 | -1.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.